Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: jake burns who wrote (958)	7/19/1998 11:18:00 PM
From: ahhaha	Read Replies (1) \| Respond to of 1510

HIV and RA. HIV in yield per patient and RA in number of patients treated. Cancer is a generic term which encompasses at least millions of forms of it. When you see a company's stock blow through the roof because they have a "cancer cure", know it's a fraud. The company at best has engineered some chemical to interfere with the reproduction of cancerous cells, inhibit abnormal cell division in the first place by providing a genetically associated missing chemical, or encourages the immune system to organize itself to destroy appropriately marked abnormal dividing cells. There are many other strategies to manage the cancer. All of these techniques inhibit or reverse the tendency for the cancer to thrive or spread, and encourage its enervation or deactivization. The patient experiences a slow reduction in the cancerous symptoms and they may never fully rid their bodies of it. In many cases they weren't born to survive genetically. Nature is unfair so man tries to level the playing field, usually with disastrous results. It was Salk and Sabin who defeated Polio, but at what price? The disease rarely occurs anywhere on the planet. It may be evolving into a new strain related to the effects of RA. The teach the immune system technique of the Polio vaccine may not work because the strain may have managed to evolve a form that refutes the immune system at the immune system level similar to but not as insidious as HIV. Without the knowledge of what other worlds have experienced, we just don't know how bad it is to defeat some diseases. I guess I'm not sure I'm enchanted with any of this stuff. Remune's biggest positive is its safety. That's why the testing of it and everything IMNR cooks, is long winded and unending. If the approval doesn't come, it would have to do with politics and in-fighting, not science or efficacy. It is highly unlikely it won't be approved in the US.